Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation. (CE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02181374
Recruitment Status : Unknown
Verified December 2015 by Xijing Hospital.
Recruitment status was:  Recruiting
First Posted : July 3, 2014
Last Update Posted : January 1, 2016
Sponsor:
Collaborators:
Tang-Du Hospital
First Affiliated Hospital Xi'an Jiaotong University
Shaanxi Provincial People's Hospital
Information provided by (Responsible Party):
Xijing Hospital

Brief Summary:
The purpose of this study is to evaluate the diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion.

Condition or disease
Ischemic Stroke

Detailed Description:
All included in the cases in 7 days of blood samples, the detection of serum NT - proBNP.Through the single factor analysis to determine the serum NT - proBNP central source sex stroke prediction values.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000 participants
Observational Model: Case Control
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation
Study Start Date : January 2012
Estimated Primary Completion Date : September 2016
Estimated Study Completion Date : September 2016

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. The diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion [ Time Frame: 34 months ]
    All included in the cases in 7 days of blood samples , the detection of serum NT - proBNP.Through the single factor analysis to determine the prediction values of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion.


Biospecimen Retention:   Samples Without DNA
NT-proBNP


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
18 ≤ Age ≤ 85; meet the clinical diagnostic criteria for acute ischemic stroke; onset within 24 hours at the same time more than one hour; it was diagnosed with experiential doctor.
Criteria

Inclusion Criteria:

  • 18 ≤ Age ≤ 85;
  • Meet the clinical diagnostic criteria for acute ischemic stroke;
  • onset within 7 days;

Exclusion Criteria:

  • Severe systemic disease (chronic inflammation, infection, blood system diseases, cancer, kidney failure, liver failure,heart failure);
  • Nearly a month history of myocardial infarction;
  • pregnant;
  • Serious neurological disease that the diagnosis is unclear;

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02181374


Contacts
Layout table for location contacts
Contact: Wen Jiang, MD 02984775361 jiangwen@fmmu.edu.cn

Locations
Layout table for location information
China, Shaanxi
The Department of Neurology, Xijing Hospital Recruiting
Xi'an, Shaanxi, China, 710032
Contact: Wen Jiang, MD    02984775361    jiangwen@fmmu.edu.cn   
Principal Investigator: Dong Wei, MD         
Sponsors and Collaborators
Xijing Hospital
Tang-Du Hospital
First Affiliated Hospital Xi'an Jiaotong University
Shaanxi Provincial People's Hospital
Investigators
Layout table for investigator information
Study Director: Wen Jiang, MD The Department of Neurology, Xijing Hospital

Additional Information:

Layout table for additonal information
Responsible Party: Xijing Hospital
ClinicalTrials.gov Identifier: NCT02181374     History of Changes
Other Study ID Numbers: Xijing-25
First Posted: July 3, 2014    Key Record Dates
Last Update Posted: January 1, 2016
Last Verified: December 2015

Keywords provided by Xijing Hospital:
atrial fibrillation
NT-proBNP
Cardioembolic Stroke

Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Atrial Fibrillation
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Arrhythmias, Cardiac
Heart Diseases
Pathologic Processes